Related Experiment Video
Updated: Apr 24, 2026
Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays
Published on: January 3, 2015
MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF
Li-Qiang Wei1, Hui-Tao Liang, Dong-Chun Qin
1Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe Road, Zhengzhou, 450052, Henan, China.
Abstract:
MicroRNAs (miRNAs) play critical roles in the development and progression of ovarian cancer. We found that miR-212 was significantly downregulated in serum and tissues from epithelial ovarian cancer (EOC) patients. Overexpression of miR-212 in ovarian cancer cells inhibited cell proliferation, migration, and invasion. Luciferase reporter assay confirmed HBEGF as a direct target of miR-212. Overexpression of miR-212 decreased HBEGF expression at both the protein and messenger RNA (mRNA) levels. Knockdown of HBEGF expression in SKOV3 cell line significantly inhibited cell growth, migration, and invasion. HBEGF mRNA level was upregulated in EOC tissues and inversely correlated with miR-212 expression in tissues. Upregulation of HBEGF could attenuate the effect induced by miR-212. These findings indicate that miR-212 displays a tumor-suppressive effect in human ovarian cancer. And miR-212 suppresses cell proliferation, migration, and invasion by targeting the HBEGF transcript, highlighting the therapeutic potential of miR-212 and HBEGF in epithelial ovarian cancer treatment.
Insights
MicroRNAs (miRNAs) are crucial in ovarian cancer. This study found miR-212 is downregulated in epithelial ovarian cancer (EOC), suppressing tumor growth and spread by targeting HBEGF, suggesting therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are key regulators in cancer development and progression.
- Ovarian cancer, particularly epithelial ovarian cancer (EOC), is a significant health concern.
- Understanding the role of specific miRNAs in EOC is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of miR-212 in epithelial ovarian cancer (EOC).
- To identify the molecular targets of miR-212 in EOC.
- To evaluate the therapeutic potential of miR-212 and its targets in EOC treatment.
Main Methods:
- Analysis of miR-212 expression in serum and tissues from EOC patients.
- Overexpression of miR-212 in ovarian cancer cell lines to assess its effects on proliferation, migration, and invasion.
- Luciferase reporter assays to confirm direct targets of miR-212.
- Western blot and qRT-PCR to measure protein and mRNA levels of target genes.
- Knockdown of target genes to evaluate their role in cancer progression.
Main Results:
- miR-212 was significantly downregulated in EOC patient samples.
- Overexpression of miR-212 inhibited ovarian cancer cell proliferation, migration, and invasion.
- HBEGF was identified as a direct target of miR-212.
- miR-212 overexpression reduced HBEGF expression at both protein and mRNA levels.
- HBEGF knockdown mimicked the tumor-suppressive effects of miR-212.
- HBEGF was upregulated in EOC tissues and inversely correlated with miR-212 levels.
Conclusions:
- miR-212 acts as a tumor suppressor in human ovarian cancer.
- miR-212 inhibits ovarian cancer cell proliferation, migration, and invasion by targeting HBEGF.
- miR-212 and HBEGF represent potential therapeutic targets for epithelial ovarian cancer treatment.
